Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study

OBJECTIVES: Our objective was to investigate the effectiveness and safety of silodosin in patients with benign prostatic hyperplasia (BPH) who switched to silodosin from another α(1) blocker because of inadequate response. METHODS: This was a prospective observational study conducted at 715 medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hiroshi, Kubono, Shinichi, Taneyama, Takehiko, Kuramoto, Kiyotoshi, Mizutani, Hideki, Tanaka, Noriko, Yoshida, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380964/
https://www.ncbi.nlm.nih.gov/pubmed/30607819
http://dx.doi.org/10.1007/s40268-018-0258-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380964/
https://www.ncbi.nlm.nih.gov/pubmed/30607819
http://dx.doi.org/10.1007/s40268-018-0258-4

Ejemplares similares